We use cookies to understand how you use our site and to improve the overall user experience. This includes personalizing content and advertising. Read our Privacy Policy
Identified from in silico studies, the set of 6 peptides offered are unique T-cell epitopes from the SARS-CoV-2 spike protein sequence. The peptide sequences are offered in net peptide quantities in individual vials of 0.25 mg each. The sequences in the set are,CV2-1 YLQPRTFLL CV2-2 GVYFASTEK CV2-3 KLPDDFTGCV CV2-4 SIIAYTMSL CV2-5 NYNYLYRLFR CV2-6 GYLQPRTFLL
Peptide Library Construction and Screening
Powerful screening tools in biological and chemical research
Size | 0.25 mg NET peptide |
References | 1. Ahmed SF et al. Preliminary identification of potential vaccine targets for the COVID-19 coronavirus (SARS-CoV-2) based on SARS-CoV immunological studies. Viruses. 2020 Mar;12(3):254. 2. Baruah V, & Bose S. Immunoinformatics‐aided identification of T cell and B cell epitopes in the surface glycoprotein of 2019‐nCoV. Journal of medical virology. 2020 May;92(5):495-500. 3. Grifoni A et al. A sequence homology and bioinformatic approach can predict candidate targets for immune responses to SARS-CoV-2. Cell host & microbe. 2020 Mar 16. 4. Coutard B et al. The spike glycoprotein of the new coronavirus 2019-nCoV contains a furin-like cleavage site absent in CoV of the same clade. Antiviral research. 2020 Apr 1;176:104742. 5. Kiyotani K et al. Bioinformatic prediction of potential T cell epitopes for SARS-Cov-2. Journal of Human Genetics (2020) 65:569–575 |
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at info@creative-peptides.com. We will endeavor to provide highly satisfying products and services.
USA
Address: SUITE 115, 17 Ramsey Road, Shirley, NY 11967, USA
Tel: 1-631-624-4882
Fax: 1-631-614-7828
Email: info@creative-peptides.com
Germany
Address: Industriepark Höchst, Gebäude G830
65929 Frankfurt am Main
Email: info@creative-peptides.com